SGLT2i: therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?

Jiajia Wu; Hong Cai; Jia Xia; Tianyi Zhang; Jiayi Yan; Xinhua Shao; Amanda Ying Wang; Jianxiao Shen; Shan Mou

doi:10.1016/j.phrs.2023.106883

SGLT2i: therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?

Jiajia Wu, Hong Cai, Jia Xia, Tianyi Zhang, Jiayi Yan, Xinhua Shao, Amanda Ying Wang^*, Jianxiao Shen^*, Shan Mou

^*Corresponding author for this work

Macquarie Medical School

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

50 Downloads (Pure)

Original language	English
Article number	106883
Pages (from-to)	1-4
Number of pages	4
Journal	Pharmacological Research
Volume	195
DOIs	https://doi.org/10.1016/j.phrs.2023.106883
Publication status	Published - Sept 2023

Bibliographical note

Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

Contrast induced acute kidney injury (CI-AKI)
Non-diabetes
Predisposing factors
Sodium-glucose cotransporter 2 inhibitors (SGLT2i)
Treatment measures

Access to Document

10.1016/j.phrs.2023.106883Licence: CC BY-NC

Publisher version (open access)Final published version, 3.71 MBLicence: CC BY-NC

Cite this

@article{5beca79201da4513b27a076c7572e6ba,

title = "SGLT2i: therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?",

keywords = "Contrast induced acute kidney injury (CI-AKI), Non-diabetes, Predisposing factors, Sodium-glucose cotransporter 2 inhibitors (SGLT2i), Treatment measures",

author = "Jiajia Wu and Hong Cai and Jia Xia and Tianyi Zhang and Jiayi Yan and Xinhua Shao and Wang, \{Amanda Ying\} and Jianxiao Shen and Shan Mou",

note = "Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher. ",

year = "2023",

month = sep,

doi = "10.1016/j.phrs.2023.106883",

language = "English",

volume = "195",

pages = "1--4",

journal = "Pharmacological Research",

issn = "1043-6618",

publisher = "Academic Press",

}

TY - JOUR

T1 - SGLT2i

T2 - therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?

AU - Wu, Jiajia

AU - Cai, Hong

AU - Xia, Jia

AU - Zhang, Tianyi

AU - Yan, Jiayi

AU - Shao, Xinhua

AU - Wang, Amanda Ying

AU - Shen, Jianxiao

AU - Mou, Shan

N1 - Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2023/9

Y1 - 2023/9

KW - Contrast induced acute kidney injury (CI-AKI)

KW - Non-diabetes

KW - Predisposing factors

KW - Sodium-glucose cotransporter 2 inhibitors (SGLT2i)

KW - Treatment measures

UR - https://www.scopus.com/pages/publications/85166678206

U2 - 10.1016/j.phrs.2023.106883

DO - 10.1016/j.phrs.2023.106883

M3 - Letter

C2 - 37544050

AN - SCOPUS:85166678206

SN - 1043-6618

VL - 195

SP - 1

EP - 4

JO - Pharmacological Research

JF - Pharmacological Research

M1 - 106883

ER -

SGLT2i: therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?

Bibliographical note

Keywords

Access to Document

Other files and links

Cite this